Prescription Fills Among Patients With Type 2 Diabetes After Hospitalization for Acute Coronary Syndrome
In this cohort study of Medicare beneficiaries with T2D, longer-term medication use following hospitalization for MI was associated with medication use at the time of discharge. These findings highlight the critical importance of this period to optimize preventive care for these high-risk individuals. Further implementation science research is needed to develop strategies to improve use of these evidence-based medications.
Authors
- Samir Soneji (ORCID: https://orcid.org/0000-0001-8735-276X)
- Hayden B. Bosworth (ORCID: https://orcid.org/0000-0001-6188-9825)
- Cassie B. Ford (ORCID: https://orcid.org/0000-0002-5940-2552)
- Michelle D. Kelsey (ORCID: https://orcid.org/0000-0002-2169-043X)
- Neha Jadeja Pagidipati (ORCID: https://orcid.org/0000-0002-5004-8868)
- Megan Oakes (ORCID: https://orcid.org/0000-0002-8307-7286)
Institutions
- Duke University (US)
- Clinical Research Institute (US)
- Durham VA Health Care System (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.47102
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Boehringer Ingelheim
- Amgen
- Eli Lilly and Company
- Pfizer
- Sanofi
- Alnylam Pharmaceuticals
- Elton John AIDS Foundation
- Novo Nordisk
- Esperion Therapeutics
- National Heart, Lung, and Blood Institute